TY - JOUR
T1 - Stillbirths
T2 - The vision for 2020
AU - Goldenberg, Robert L.
AU - McClure, Elizabeth M.
AU - Bhutta, Zulfiqar A.
AU - Belizán, José M.
AU - Reddy, Uma M.
AU - Rubens, Craig E.
AU - Mabeya, Hillary
AU - Flenady, Vicki
AU - Darmstadt, Gary L.
N1 - Funding Information:
We thank Joy E Lawn, Robert Pattinson, and J Frederik Frøen for their extensive contributions to this article, and the Bill & Melinda Gates Foundation, the Global Alliance to Prevent Prematurity and Stillbirth, the International Stillbirth Alliance, and the Partnership for Maternal, Newborn and Child Health for their financial support to The Lancet's Stillbirths Series. CER has received funding from the Bill & Melinda Gates Foundation, and support for RLG and EMM was provided by the National Institute of Child Health and Human Development Global Network, and the Maternal and Neonatal Directed Assessment of Technology project of the Research Triangle Institute, Research Triangle Park, NC, USA.
PY - 2011
Y1 - 2011
N2 - Stillbirth is a common adverse pregnancy outcome, with nearly 3 million third-trimester stillbirths occurring worldwide each year. 98 occur in low-income and middle-income countries, and more than 1 million stillbirths occur in the intrapartum period, despite many being preventable. Nevertheless, stillbirth is practically unrecognised as a public health issue and few data are reported. In this final paper in the Stillbirths Series, we call for inclusion of stillbirth as a recognised outcome in all relevant international health reports and initiatives. We ask every country to develop and implement a plan to improve maternal and neonatal health that includes a reduction in stillbirths, and to count stillbirths in their vital statistics and other health outcome surveillance systems. We also ask for increased investment in stillbirth-related research, and especially research aimed at identifying and addressing barriers to the aversion of stillbirths within the maternal and neonatal health systems of low-income and middle-income countries. Finally, we ask all those interested in reducing stillbirths to join with advocates for the improvement of other pregnancy-related outcomes, for mothers and their offspring, so that a united front for improved pregnancy and neonatal care for all will become a reality.
AB - Stillbirth is a common adverse pregnancy outcome, with nearly 3 million third-trimester stillbirths occurring worldwide each year. 98 occur in low-income and middle-income countries, and more than 1 million stillbirths occur in the intrapartum period, despite many being preventable. Nevertheless, stillbirth is practically unrecognised as a public health issue and few data are reported. In this final paper in the Stillbirths Series, we call for inclusion of stillbirth as a recognised outcome in all relevant international health reports and initiatives. We ask every country to develop and implement a plan to improve maternal and neonatal health that includes a reduction in stillbirths, and to count stillbirths in their vital statistics and other health outcome surveillance systems. We also ask for increased investment in stillbirth-related research, and especially research aimed at identifying and addressing barriers to the aversion of stillbirths within the maternal and neonatal health systems of low-income and middle-income countries. Finally, we ask all those interested in reducing stillbirths to join with advocates for the improvement of other pregnancy-related outcomes, for mothers and their offspring, so that a united front for improved pregnancy and neonatal care for all will become a reality.
UR - http://www.scopus.com/inward/record.url?scp=79956350747&partnerID=8YFLogxK
U2 - 10.1016/S0140-6736(10)62235-0
DO - 10.1016/S0140-6736(10)62235-0
M3 - Review article
C2 - 21496912
AN - SCOPUS:79956350747
SN - 0140-6736
VL - 377
SP - 1798
EP - 1805
JO - The Lancet
JF - The Lancet
IS - 9779
ER -
